Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations

References

• Valleri M, Mura P, Maestrelli F, et al. Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm 2004;30:525–34
   PubMed Web of Science ®Google Scholar
• Goel H, Rai P, Rana V, Tiwary AK. Orally disintegrating systems: innovations informulation and technology. Recent Patents Drug Deliv Formulation 2008;2:258–74
   PubMedGoogle Scholar
• Mc Laughlin R, Banbury S, Crowley K. Orally disintegrating tablets: the effect of recent FDA guidance on ODT technologies and applications. PharmTech [Online] 2006. Available from: http://www.pharmtech.com/pharmtech/article/articleDetail.jsp?id=623097&pageID=1&sk=&date= [last accessed 15 Jan 2010]
   Google Scholar
• Hirani JJ, Rathod DA, Vadalia KR. Orally disintegrating tablets: a review. Trop J Pharm Res 2009;8:161–72
   Web of Science ®Google Scholar
• Fu Y, Yang S, Jeong SH, et al. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst 2004;21:433–75
   PubMed Web of Science ®Google Scholar
• Hamlen S, MacGregor K. Patient compliance study: new data shows drug delivery has positive impact on patient compliance. Drug Dev Deliv 2011;11:30–3
   Google Scholar
• Brown D. Orally disintegrating tablets: taste over speed. Drug Deliv Tech 2003;3:58–61
   Google Scholar
• Kayumba PC, Huyghebaert N, Cordella C, et al. Quinine sulphate pellets for flexible pediatric drug dosing: formulation development and evaluation of taste-masking efficiency using the electronic tongue. Eur J Pharm Biopharm 2007;66:460–5
   PubMed Web of Science ®Google Scholar
• Hamashita T, Matsuzaki M, Ono T, et al. Granulation of core particles suitable for film coating by agitation fluidized bed II. A proposal of a rapid dissolution test for evaluation of bitter taste of ibuprofen. Chem Pharm Bull 2008;56:883–7
   PubMed Web of Science ®Google Scholar
• Khattab IS, Zaghloul AA, Afouna MI. Studies on the development of rapidly disintegrating hyoscine butylbromide tablets. Drug Discov Ther 2007;1:61–4
   PubMedGoogle Scholar
• Ishikawa T, Watanabe Y, Utoguchi N, Matsumoto M. Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method. Chem Pharm Bull 1999;47:1451–4
   PubMed Web of Science ®Google Scholar
• Guhmann M, Preis M, Gerber F, et al. Development of oral taste masked diclofenac formulations using a taste sensing system. Int J Pharm 2012;38:81–90
   Web of Science ®Google Scholar
• Woertz K, Tissen C, Kleinebudde P, Breitkreutz J. Rational development of taste masked oral liquids guided by an electronic tongue. Int J Pharm 2010;400:114–23
   PubMed Web of Science ®Google Scholar
• Sallmann AR. The history of diclofenac. Am J Med 1986;80:29–33
   PubMed Web of Science ®Google Scholar
• Reiner A, Reiner G. Pharmaceutical compositions and methods of treatment based on diclofenac. US patent 7,482,377. 2009
   Google Scholar
• European Directorate for quality of Medicines (EDQM). Strasbourg: European Pharmacopoeia; 2008. Chapter 2.9.1 Tablets
   Google Scholar
• Washington N, Washington C, Wilson CG. Drug delivery to the oral cavity or mouth. Physiological pharmaceutics: barriers to drug absorption. 2nd ed. Boca Raton: CRC Press; 2000:38–58
   Google Scholar
• Schindler JG, Schindler MM. Bioelektrochemische membranelektroden. Berlin, Germany: Walter de Gruyter; 1983
   Google Scholar
• Plambeck JA. Electroanalytical chemistry: basic principles and applications. New York (NY): Wiley-VCH; 1982
   Google Scholar
• Woertz K, Tissen C, Kleinebudde P, Breitkreutz J. Performance qualification of an electronic tongue based on ICH guideline Q2. J Pharm Biomed Anal 2010;51:497–506
   PubMed Web of Science ®Google Scholar
• Preis M, Pein M, Breitkreutz J. Development of a taste masked orodispersible film containing dimenhydrate. Pharmaceutics 2012;4:551–62
   PubMedGoogle Scholar
• European Directorate for quality of Medicines (EDQM). Pharmaeuropa 1998;10:547
   Google Scholar
• Guhmann M, Thommes M, Gerber F, et al. Design of biorelevant test setups for the prediction of diclofenac in vivo features after oral administration. Pharm Res 2013;30:1483–501
   PubMed Web of Science ®Google Scholar
• Sharma S, Lewis S. Taste-masking technologies: a review. Int J Pharm Pharm Sci 2010;2:6–13
   Google Scholar
• Sato T, Nishishita K, Okada Y, Toda K. Effect of gap junction blocker beta-glycyrrhetinic acid on taste disk cells in frog. Cell Mol Neurobiol 2009;29:503–12
   PubMed Web of Science ®Google Scholar
• Lyall V, Phan TH, Ren Z, et al. Regulation of the putative TRPV1t salt taste receptor by phosphatidylinositol 4,5-bisphosphate. J Neurophysiol 2010;103:1337–49
   PubMed Web of Science ®Google Scholar
• Maniruzzaman M, Boateng JS, Bonnefille M, et al. Taste masking of paracetamol by hot-melt extrusion: an in vitro and in vivo evaluation. Eur J Pharm Biopharm 2012;80:433–42
   PubMed Web of Science ®Google Scholar
• Douroumis DD, Gryczke A, Schminke S. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets. AAPS PharmSciTech 2011;12:141–51
   PubMed Web of Science ®Google Scholar
• Sikandar MK, Malviya R, Sharma PK. Taste masking: an important pharmaceutical technology for the improvement of organoleptic property of pharmaceutical active agents. Eur J Biol Sci 2011;3:67–71
   Google Scholar
• Guffon N, Kibleur Y, Copalu W, et al. Developing a new formulation of sodium phenylbutyrate. Arch Dis Child 2012;97:1081–5
   PubMed Web of Science ®Google Scholar
• Suzuki H, Onishi H, Takahashi Y, et al. Development of oral acetaminophen chewable tablets with inhibited bitter taste. Int J Pharm 2003;251:123–32
   PubMed Web of Science ®Google Scholar
• Kawano Y, Ito A, Sasatsu M, et al. Preparation and evaluation of taste masked orally disintegrating tablets with granules made by the wet granulation method. Yakugaku Zasshi 2010;130:1737–42
   PubMed Web of Science ®Google Scholar
• Handbook of Pharmaceutical Excipients. 4th ed. Washington and London: The American Pharmaceutical Association and The Royal Pharmaceutical Society; 2003:158
   Google Scholar
• Koizumi KI, Watanabe Y, Morita K, et al. New method of preparing high-porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. Int J Pharm 1997;152:127–31
   Web of Science ®Google Scholar
• Bi Y, Sunada H, Yonezawa Y, et al. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull 1996;14:2121–7
   Google Scholar
• Narazaki R, Harada T, Takami N, et al. A new method for disintegration studies of rapid disintegrating tablet. Chem Pharm Bull 2004;52:704–7
   PubMed Web of Science ®Google Scholar
• Shukla D, Chakraborty S, Singh S, Mishra B. Mouth dissolving tablets II: an overview of evaluation techniques. Sci Pharm 2009;77:327–41
   Google Scholar
• Reynolds JEF, Prasad AB. Martindale: the extra pharmacopeia. 28th ed. London: The Pharmacopeial Press; 2002
   Google Scholar
• Douroumis D. Orally disintegrating dosage forms and taste-masking technologies. Expert Opin Drug Deliv 2011;8:665–75
   PubMed Web of Science ®Google Scholar
• Center for Drug Evaluation and Research (CDER). Guidance for Industry: Orally Disintegrating Tablets. US Food and Drug Administration [Online] Dec 2008. Available from: http://www.fda.gov/OHRMS/DOCKETS/98fr/FDA-2007-D-0365-gdl.pdf [last accessed 19 Nov 2009]
   Google Scholar
• Selen A. Biorelevant dissolution testing: characterizing the product for the patient. AAPS Annual Meeting [Online]; 8 Nov 2009. Available from: http://mediaserver.aaps.org/meetings/09AM/Slides/11.8.09_Sun/Room%20408%20A/0830/Arzu_Selen.pdf [last accessed 4 Jun 2012]
   Google Scholar